Results 1 to 10 of about 1,248,685 (314)

Prognostic understanding interventions in patients with advanced cancer: a systematic review [PDF]

open access: yesFrontiers in Psychology
BackgroundMost patients with advanced cancer have an inadequate understanding of their prognosis, and there are few interventions aimed at enhancing their prognostic understanding, with the effectiveness of these interventions remaining controversial ...
Li Dong   +5 more
doaj   +2 more sources

The application status of dignity therapy in end-stage cancer patients at home and abroad (尊严疗法在国内外终末期癌症患者中的应用现状)

open access: yes中西医结合护理, 2021
Dignity therapy is a personalized psychological intervention method for advanced cancer patients based on the dignity model. Dignity therapy reviews the patient's life through in-depth conversations with patients about dignity issues through interviews ...
MIAO Jinhu (苗金虎)   +9 more
doaj   +1 more source

Research progress of advance care planning for patients with advanced cancer (预立医疗照护计划在肿瘤晚期患者中的应用研究进展)

open access: yes中西医结合护理, 2022
Patients with advanced cancer usually suffer from both physical pain and mentally distress. The advance care planning can effectively guarantee the autonomy of patients with advance cancer, improve their quality of life in the terminal stage, and reduce ...
YIN Sujin (尹苏近)
doaj   +1 more source

Preferences for Renal Cell Carcinoma Pharmacological Treatment: A Discrete Choice Experiment in Patients and Oncologists

open access: yesFrontiers in Oncology, 2022
IntroductionThe purpose of this investigation was to explore patients’ and oncologists’ preferences for the characteristics of a pharmacological regimen for patients with advanced renal cell carcinoma (aRCC).Material and MethodsCross-sectional ...
Ovidio Fernández   +13 more
doaj   +1 more source

Polycomb repressive complex 2 mutations predict survival benefit in advanced cancer patients treated with immune checkpoint inhibitors

open access: yesImmuno-Oncology and Technology, 2021
Background: Numerous biomarkers are being tested to enhance the ability of clinicians to predict responses and prognosis after treatment with immune checkpoint inhibitors (ICIs).
P.J. Vlachostergios
doaj   +1 more source

Is Neuropathic Pain a Good Marker of Peripheral Neuropathy in Hospice Patients with Advanced Cancer? The Single Center Pilot Study

open access: yesDiagnostics, 2021
Neuropathic pain (NP) affects approximately 30% of patients with advanced cancer. The prevalence of neuropathic pain related to peripheral neuropathy (NP-RPN) in these patients is not known.
Joanna Drat-Gzubicka   +4 more
doaj   +1 more source

Autologous engineered T cell receptor therapy in advanced cancer

open access: yesHuman Vaccines & Immunotherapeutics, 2023
To overcome challenges associated with adoptive cell therapy (ACT), we developed a personalized autologous T-cell therapy program. Patients with advanced cancer with HLA-A *02:01 allele and tumor expression of PRAME, MAGEA1, MAGEA4, MAGEA8, NY-ESO-1 ...
Apostolia M. Tsimberidou   +3 more
doaj   +1 more source

Pathways to Acceptance in Participants of Advanced Cancer Online Support Groups

open access: yesMedicina, 2021
Background and Objectives: Individuals with cancer, especially advanced cancer, are faced with numerous difficulties associated with the disease, including an earlier death than expected. Those who are able to confront and accept the hardships associated
Christina Francesca Pereira   +5 more
doaj   +1 more source

Managing Cancer and Living Meaningfully for Advanced Cancer: A Systematic Review

open access: yesJurnal Ners, 2020
Introduction: Managing Cancer and Living Meaningfully (CALM) is a supportive-expressive psychotherapy designed to address such barriers and to facilitate communication of mortality-related concerns in patients facing advanced disease and their primary ...
Shenda Maulina Wulandari   +2 more
doaj   +1 more source

Advancements in Cancer Immunotherapies

open access: yesVaccines, 2022
Recent work has suggested involvement of the immune system in biological therapies specifically targeting tumor microenvironment. Substantial advancement in the treatment of malignant tumors utilizing immune cells, most importantly T cells that play a key role in cell-mediated immunity, have led to success in clinical trials.
Ruchi Roy, Sunil Singh, Sweta Misra
openaire   +3 more sources

Home - About - Disclaimer - Privacy